tldrdailynews.com logo

GLP-1 Weight-Loss Drugs Now Used by 11% of Americans

1 min read
Source: Gizmodo
GLP-1 Weight-Loss Drugs Now Used by 11% of Americans
Photo: Gizmodo
TL;DR

A Gallup poll of 5,065 U.S. adults (May 28–June 5, 2026) finds 11% are currently using GLP-1 weight‑loss drugs (up from 8% in 2025), with 15% having ever tried them and 91% having heard of them; the trend follows FDA approvals for Wegovy (2021) and Zepbound (2023) and coincides with ongoing, but not universal, changes in obesity rates (self‑reported around the mid‑30s). Most users report brand-name drugs, though some use compounded versions; side effects like nausea are possible, while some data suggest reduced cravings, and oral Wegovy (approved 2025) signals more delivery options in the future.

Topics:businesshealth#gallup#glp-1#health#obesity#wegovy#weight-loss
Share this article
  1. 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy  Gizmodo
  2. More Americans Than Ever Are Taking Weight-Loss Drugs  The New York Times
  3. In U.S., GLP-1 Usage Reaches New High  Gallup News
  4. U.S. Obesity Rate Drops As GLP-1 Usage Grows  Forbes
  5. Americans are taking GLP-1 drugs in record numbers  The Washington Post

Want the full story? Read the original reporting

Read on Gizmodo